FDA Inspection 1301800 — Highland Laboratories Inc

Highland Laboratories Inc — FEI 3050043

The FDA completed an inspection of Highland Laboratories Inc on Feb 6, 2026 in Mount Angel, OR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 20 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
Feb 6, 2026
Fiscal Year
2026
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Mount Angel, OR (United States)

Citations

IDCFRDescription
1557821 CFR 111.155(c)Components - quarantine
1564521 CFR 111.455(c)Hold - mix-up, contamination, deterioration
1568121 CFR 111.315(d)Standard reference materials; criteria for selecting
1569821 CFR 111.320(a)Examination, testing; appropriate
1570221 CFR 111.320(b)Examination, testing; scientifically valid
1572321 CFR 111.365(i)Metal, foreign material
1586121 CFR 111.75(a)(2)(ii)(A)Component - qualify supplier
1595321 CFR 111.113(a)(1)Quality control production, process control; material review, disposition
1597221 CFR 111.120(b)Quality control operations - specifications; components, packaging, labels
1598021 CFR 111.123(a)(4)Quality control operations - material review, disposition decision
1604021 CFR 111.610(a)Records - available; FDA
2281821 CFR 111.10(b)Hygienic practices
2281921 CFR 111.12Personnel - qualifications
2282321 CFR 111.15(b)Physical plant - clean and sanitary
2283121 CFR 111.20(d)Physical plant - construction
2283621 CFR 111.27(a)Equipment - design - appropriate and suitable
2284321 CFR 111.70(b)Specifications - components
2284721 CFR 111.70(e)Specifications - finished dietary supplement
2288421 CFR 111.205(a)Master manufacturing record - prepared
2289021 CFR 111.260Batch record - required information